Bioengineered Artificial Mesenchimal Sheet

N/A

Report date: 2023/08/01 20:00:44

Base Information

Drug NameBioengineered Artificial Mesenchimal Sheet

Drug Alias NameBAMSAdipose Tissue Stem Cells on Biological MatrixAllogenic Adipose-derived Adult Mesenchymal Stem Cells Expanded on Fibrinhyaluronic Biological Matrix

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsVaricose Ulcer

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAndalusian Network For Design And Translation Of Advanced Therapies

China Registration ClassN/A

Develop Information

Active CompaniesAndalusian Network For Design And Translation Of Advanced Therapies

Inactive CompaniesN/A

Active IndicationsVaricose Ulcer

Inactive IndicationsN/A

Other Information

ATC CodeN/A